🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "targeted steps to tackle household expense issues" in next month's financial statement.

Speaking to media outlets, she stated that lowering inflation is a joint task of both the government and the central bank.

The UK's price growth is expected to be the highest among the G7 industrialized countries this year and the following year.

Possible Utility Cost Measures

Reports indicate the administration could take action to lower utility costs, for example by cutting the current 5% rate of value-added tax applied on energy supplies.

A further approach is to lower some of the policy costs presently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much space there is for these actions.

The expectation from most experts is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her self-imposed borrowing rules.

Previously on the same day, analysis showed there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of expectations.

"There's a shared job between the central bank and the administration to further reduce some of the sources of inflation," Reeves told the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and Global Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not changed her vow to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and trade tensions for the Budget tax moves, likely to be focused on those "with the broadest shoulders."

Global Economic Tensions

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests always take priority."

Last week's statement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech manufacturing led US President Donald Trump to threaten an extra 100% import tax on goods from China, raising the risk of an all-out commercial conflict between the two global powers.

The American finance chief described China's action "economic coercion" and "a global supply chain power grab."

Asked about accepting the US offer to join its conflict with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and called on the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the world economy and creates additional challenges."

"I believe there are sectors where we must challenge Chinese policies, but there are also valuable opportunities to export to China's economy, including financial services and other areas of the economy. We've got to achieve that equilibrium appropriate."

The chancellor also affirmed she was working with other major economies "on our own essential resources plan, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the price the NHS spends on pharmaceuticals could increase as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

Some of the biggest global drug companies have said lately that they are either halting or scrapping operations in the UK, with several blaming the insufficient payments they are obtaining.

Recently, the Science Minister said the price the NHS pays for medicines would have to go up to halt businesses and drug research funding departing from the UK.

Reeves informed the BBC: "We have seen because of the cost structure, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other European countries."

"We want to guarantee that patients getting care from the NHS are can receive the finest critical drugs in the world. And so we are reviewing these issues, and... aiming to attract increased investment into the UK."